Naprostad (Naproxen)

Naproxen works by blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. By reducing prostaglandin synthesis, it diminishes the inflammatory response, pain signaling, and fever generation at the affected sites.

The specific dose of Naprostad is determined by the prescribing clinician based on the patient’s condition, age, weight, and overall health. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety of naproxen during pregnancy and lactation depends on the trimester and individual risk factors. It is generally avoided in the third trimester and used only if the potential benefit outweighs the risk. Breastfeeding mothers should consult their healthcare provider before using Naprostad.

To place an order, submit an enquiry on the Naprostad product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both naproxen (Naprostad) and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen has a longer half‑life, often allowing twice‑daily dosing, whereas ibuprofen typically requires three to four doses per day. Choice between them depends on clinical response, dosing convenience, and individual tolerance.

Naprostad should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original container, protect them from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Naprostad is taken orally with a full glass of water. It may be taken with or without food, although taking it with food can reduce stomach irritation. Patients should swallow the tablet whole and not split, crush, or chew it unless instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, and renal impairment. Patients should be vigilant for signs of severe abdominal pain, black stools, sudden shortness of breath, chest pain, or unexplained swelling and seek medical attention promptly.

Individuals with a known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment should not use Naprostad unless specifically directed by a physician.